Back
Zevra Therapeutics Vs. BioCardia Industry Stock Comparison
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
9.49
Seasonality Move:
6.65%
Sell
32
BCDA
BioCardia
Last Price:
2.36
Seasonality Move:
5.73%
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $9.43. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
BioCardia (BCDA)
is a Sell
Is BioCardia a Buy, Sell or Hold?
- The current BioCardia [BCDA] share price is $2.28. The Score for BCDA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BCDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $9.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing selling pressure, which indicates risk of future bearish movement.
BCDA Stock Price Chart
ZVRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 63.79 | Buy |
| Chaikin Money Flow: | -210557 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.19 - 9.15) | Buy |
| Bollinger Bands (100): | (6.61 - 8.53) | Buy |
BCDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 48.84 | Sell |
| Chaikin Money Flow: | -21031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.11 - 2.47) | Sell |
| Bollinger Bands (100): | (2.33 - 3.07) | Sell |
ZVRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.1 | Buy |
| 20-day SMA: | 8.84 | Buy |
| 50-day SMA: | 8.26 | Buy |
| 200-day SMA: | 6.39 | Buy |
| 8-day EMA: | 9.2 | Buy |
| 20-day EMA: | 8.88 | Buy |
| 50-day EMA: | 8.33 | Buy |
| 200-day EMA: | 6.82 | Buy |
BCDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.12 | Buy |
| 20-day SMA: | 2.25 | Buy |
| 50-day SMA: | 2.51 | Sell |
| 200-day SMA: | 4.06 | Sell |
| 8-day EMA: | 2.21 | Buy |
| 20-day EMA: | 2.26 | Buy |
| 50-day EMA: | 2.47 | Sell |
| 200-day EMA: | 4.78 | Sell |
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.
BioCardia Earnings Growth & BCDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.38 per share, and an increase next year of $2.30 per share.
Zevra Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioCardia Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||